As head of a dubious pharmaceutical company, Ramaswamy pushed an Alzheimers drug he knew didn't work

The advertisement concerned intepirdine, an Alzheimer's drug candidate developed by Axovant Sciences, a company Ramaswamy founded in 2014.

Topics: Health care.

• would dismantle Medicare and Medicaid kicking 500,000 Ohioans off their insurance … and cutting rural hospital funding

  A campaign advertisement, "Mistakes" · October 6, 2026

• As Health Director, Amy worked with republicans to hold big drug companies accountable for the opioid crisis, bringing millions back to Ohio to lower healthcare costs

  A campaign advertisement, "Leader" · October 5, 2026

• He made hundreds of millions of dollars scamming people like me.

  A campaign television advertisement, "Norm" · September 21, 2026 · PolitiFact: Mostly False

• …Vivek Ramaswamy is spending millions on attack ads, even using AI to lie about my family.

  A campaign television advertisement, "Garbage" · September 10, 2026

Every claim filed under Amy Acton

Data from Wikipedia, CC BY-SA 4.0: Sio Gene Therapies (formerly Axovant Gene Therapies)

1. Medium Buying post with the ad "Important" · Medium Buying (X) · 2026-09-07 · accessed 2026-10-03
2. Truth Squad: Fact checking attack ads as race for Ohio governor heats up · WKRC Local 12 (YouTube channel LOCAL 12) · 2026-09-08 · accessed 2026-10-05
3. Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer's Disease (Form 8-K, exhibit 99.1) · U.S. Securities and Exchange Commission (EDGAR) · 2017-09-26 · accessed 2026-10-03
4. Sio Gene Therapies (formerly Axovant Gene Therapies) · Wikipedia · accessed 2026-10-05